2006 Presentations

Second quarter & half year results 2006

27 July 2006

Presented by:

David Brennan (Chief Executive Officer)
Jon Symonds (Chief Financial Officer)

Downloads

• Presentation (PDF 1135kb)

Buisness review 2006

8 June 2006

Downloads

• Presenters biographies (PDF 466kb)
• Introduction - David Brennan (PDF 53kb)
• Pipeline overview - John Patterson (PDF 402kb)
• Crestor - Elaine campbell (PDF 1529kb)
• AZD6140, AGI- 1067 - Howard Hutchinson (PDF 144kb)
• Cardiovascular - Gunnar Olsson (PDF 235kb)
• Seroquel - Carolyn Fitzsimons (PDF 368kb)
• NXY-059 - Tomas Odergren (PDF 255kb)
• Neuroscience - Ihor Rak (PDF 365kb)
• Respiratory & Inflammation - Rodger McMillan (PDF 610kb)
• Infection - John Rex (PDF 173kb)
• Zactima, AZD2171 - Alan Barge (PDF 631kb)
• Oncology - Brent Vose (PDF 468kb)
• Buisness Overview - Jon Symonds (PDF 130kb)

2006 Annual General Meeting

27 April 2006

Downloads

• David Brennan (Chief Executive Officer) (PDF 983kb)

Education seminar on Merck arrangements

14 March 2006

Downloads

• Presentation with script (PDF 711kb)

Fourth quarter and full year results 2005

2 February 2006

Downloads

• Presentation (PDF 304kb)